NovoCure NVCR
NASDAQ NVCR
$15.36 -0.56 (-3.52%)
As of: Oct 2, 2026 · 1:40 PM EDT

NovoCure (NVCR) Net Equity Issued and Repurchased (2014 - 2026)

Updated

NovoCure (NVCR) posted Net Equity Issued and Repurchased of $2.46 million for Q2 2026, up 14.9% from $2.14 million a year earlier and up 529.5% from the prior quarter.

Analysis

NovoCure (NVCR) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at NovoCure was $3.46 million, down 63.4% year-over-year; for FY2025, it was $6.11 million, up 47.3% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -26.5% (FY2020 to FY2025).
  • In prior years, NovoCure's Net Equity Issued and Repurchased was $4.15 million in FY2024 (-63.5%), $11.38 million in FY2023 (+10.5%), $10.3 million in FY2022 (-51.4%) and $21.18 million in FY2021 (-25.5%).
  • The Q2 2026 figure stands as the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last seven quarters, with growth averaging 84.5%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2025, with growth of 438.0%; the weakest was Q4 2025, with a decline of 96.1%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $390,000 (Q1 2026), $77,000 (Q4 2025) and $538,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 3.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 65.60 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 20.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 5.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 53.80 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 NovoCure 1.86 Bn -496.48 Mn 142.48 Mn 2.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.46 Mn
Mar 31, 2026 390,000.00
Dec 31, 2025 77,000.00
Sep 30, 2025 538,000.00
Jun 30, 2025 2.14 Mn
Mar 31, 2025 5.25 Mn
Dec 31, 2024 1.96 Mn
Sep 30, 2024 100,000.00
Jun 30, 2024 2.19 Mn
Mar 31, 2024 213,000.00
Dec 31, 2023 377,000.00
Sep 30, 2023 1.17 Mn
Jun 30, 2023 4.62 Mn
Mar 31, 2023 5.21 Mn
Dec 31, 2022 952,000.00
Sep 30, 2022 4.21 Mn
Jun 30, 2022 2.76 Mn
Mar 31, 2022 3.15 Mn
Dec 31, 2021 1.48 Mn
Sep 30, 2021 3.04 Mn
API Access

NovoCure Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=NVCR&period=max&api_key=YOUR_API_KEY